These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34546079)

  • 1. Budget Impact of the Flash Continuous Glucose Monitoring System in Medicaid Diabetes Beneficiaries Treated with Intensive Insulin Therapy.
    Frank JR; Blissett D; Hellmund R; Virdi N
    Diabetes Technol Ther; 2021 Sep; 23(S3):S36-S44. PubMed ID: 34546079
    [No Abstract]   [Full Text] [Related]  

  • 2. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
    Reddy M; Jugnee N; Anantharaja S; Oliver N
    Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2019; 19(8):1-108. PubMed ID: 31942227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flash CGM associated with event reduction in nonintensive diabetes therapy.
    Miller E; Kerr MSD; Roberts GJ; Nabutovsky Y; Wright E
    Am J Manag Care; 2021 Nov; 27(11):e372-e377. PubMed ID: 34784145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study.
    Gilbert TR; Noar A; Blalock O; Polonsky WH
    Diabetes Technol Ther; 2021 Mar; 23(S1):S35-S39. PubMed ID: 33470882
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessing non-adjunctive CGM safety at home and in new markets (ANSHIN).
    Chao C; Andrade SB; Bergford S; Calhoun P; Welsh JB; Walker TC;
    Endocrinol Diabetes Metab; 2023 May; 6(3):e414. PubMed ID: 36864014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Adherence, A1C Improvement, and Type of Continuous Glucose Monitoring System in People with Type 1 Diabetes or Type 2 Diabetes Treated with Intensive Insulin Therapy.
    Nemlekar PM; Hannah KL; Green CR; Norman GJ
    Diabetes Ther; 2024 Mar; 15(3):639-648. PubMed ID: 38289464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
    Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
    Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry.
    Wong JC; Foster NC; Maahs DM; Raghinaru D; Bergenstal RM; Ahmann AJ; Peters AL; Bode BW; Aleppo G; Hirsch IB; Kleis L; Chase HP; DuBose SN; Miller KM; Beck RW; Adi S;
    Diabetes Care; 2014 Oct; 37(10):2702-9. PubMed ID: 25011947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
    Lanzinger S; Best F; Bergmann T; Laimer M; Lipovsky B; Danne T; Zimny S; Bramlage P; Meyhöfer S; Holl RW
    Diabetes Technol Ther; 2022 Oct; 24(10):763-769. PubMed ID: 35653726
    [No Abstract]   [Full Text] [Related]  

  • 13. Personal Continuous Glucose Monitoring Use Among Adults with Type 2 Diabetes: Clinical Efficacy and Economic Impacts.
    Oser TK; Litchman ML; Allen NA; Kwan BM; Fisher L; Jortberg BT; Polonsky WH; Oser SM
    Curr Diab Rep; 2021 Dec; 21(11):49. PubMed ID: 34882273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia.
    Reddy M; Jugnee N; El Laboudi A; Spanudakis E; Anantharaja S; Oliver N
    Diabet Med; 2018 Apr; 35(4):483-490. PubMed ID: 29230878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent Use of Continuous Glucose Monitoring: A New Paradigm in Treatment of Type 2 Diabetes.
    Saboo B; Unnikrishnan R; Kesavadev J; Tiwaskar M; Czupryniak L; Chawla M; Choudhary P; Battelino T; Agarwal S; Danne T; Mohan V
    J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility Criteria.
    Galindo RJ; Aleppo G; Parkin CG; Baidal DA; Carlson AL; Cengiz E; Forlenza GP; Kruger DF; Levy C; McGill JB; Umpierrez GE
    J Diabetes Sci Technol; 2024 Jul; 18(4):974-987. PubMed ID: 36524477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
    Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
    Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis Estimating the Potential Cost Impact of Utilizing Flash Glucose Monitoring with Optional Alarms in Swedish Adults with Diabetes with Impaired Awareness of Hypoglycaemia, Using Intensive Insulin.
    Blissett DB; Attvall S; Hellmund RA
    Diabetes Ther; 2021 Aug; 12(8):2179-2193. PubMed ID: 34232483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.